Biohaven Pharmaceutical Holding Co Ltd.

Rafferty Asset Management, LLC

Report date

9/30/2022

Quarter

2022 Q3

Filed

11/14/2022

Shares

45,902

Value ($000)

6,939

Weight

0.1%

2019 Q4 - 2022 Q3 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q3	11/14/2022	6,939	0.1%	45,902	9/30/2022
2022 Q2	8/12/2022	3,858	0.0%	26,479	6/30/2022
2022 Q1	5/13/2022	5,336	0.0%	45,001	3/31/2022
2021 Q4	2/10/2022	7,287	0.0%	52,876	12/31/2021
2021 Q3	11/10/2021	3,217	0.0%	23,156	9/30/2021
2021 Q2	8/10/2021	2,411	0.0%	24,837	6/30/2021
2021 Q1	5/10/2021	2,793	0.0%	40,868	3/31/2021
2020 Q4	2/10/2021	915	0.0%	10,680	12/31/2020
2020 Q3	11/13/2020	2,185	0.0%	33,608	9/30/2020
2020 Q2	8/7/2020	1,058	0.0%	14,471	6/30/2020
2020 Q1	5/15/2020	233	0.0%	6,840	3/31/2020
2019 Q4	2/10/2020	3,160	0.0%	58,043	12/31/2019